- Companies
- Translational Development
Translational Development Valuation Multiples
Translational Development is valued at $210M as of November 2026. In the last fiscal year, Translational Development EBITDA was $6M.
Translational Development Overview
About Translational Development
Translational Development Acquisition Corp is a newly organized blank check company.
Founded
2022
HQ
Employees
2
Financials (Last FY)
EV
$211M
Valuation Multiples
Start free trialTranslational Development Financials
Translational Development reported last fiscal year revenue of - and EBITDA of $6M.
In the same fiscal year, Translational Development generated $6M in EBITDA and $6M in net income.
Translational Development P&L
In the most recent fiscal year, Translational Development reported revenue of - and EBITDA of $6M.
Translational Development is profitable as of last fiscal year, with EBITDA margin of - and net margin of -.
Financial data powered by Morningstar, Inc.
Translational Development Stock Performance
Translational Development has current market cap of $210M, and enterprise value of $211M.
Market Cap Evolution
Translational Development's stock price is $10.87.
Translational Development share price increased by 0.4% in the last 30 days, and by 4.4% in the last year.
Translational Development has an EPS (earnings per share) of $0.33.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $211M | $210M | 0.0% | 0.4% | 0.1% | 4.4% | $0.33 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialTranslational Development Valuation Multiples
Translational Development trades at 33.1x EV/EBITDA.
Translational Development Financial Valuation Multiples
As of November 8, 2026, Translational Development has market cap of $210M and EV of $211M.
Translational Development has a P/E ratio of 33.0x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Translational Development Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Translational Development Margins & Growth Rates
Translational Development Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Translational Development Operational KPIs
Translational Development's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.5M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
Translational Development Competitors
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
This data is available for Pro users. Sign up to see all Translational Development competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Translational Development
| When was Translational Development founded? | Translational Development was founded in 2022. |
| Where is Translational Development headquartered? | Translational Development is headquartered in United States. |
| How many employees does Translational Development have? | As of today, Translational Development has over 2 employees. |
| Is Translational Development publicly listed? | Yes, Translational Development is a public company listed on Nasdaq. |
| What is the stock symbol of Translational Development? | Translational Development trades under TDAC ticker. |
| When did Translational Development go public? | Translational Development went public in 2025. |
| Who are competitors of Translational Development? | Translational Development main competitors include |
| What is the current market cap of Translational Development? | Translational Development's current market cap is $210M. |
| Is Translational Development profitable? | No, Translational Development is not profitable. |
| How many companies Translational Development has acquired to date? | Translational Development hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Translational Development has invested to date? | Translational Development hasn't invested in any companies yet (or none have been disclosed publicly). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




